Howard Capital Management Inc. purchased a new position in shares of Willis Towers Watson Public Limited (NASDAQ:WTW – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 646 shares of the company’s stock, valued at approximately $202,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Fidelis Capital Partners LLC increased its position in Willis Towers Watson Public by 3.1% during the third quarter. Fidelis Capital Partners LLC now owns 1,223 shares of the company’s stock worth $357,000 after purchasing an additional 37 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its position in Willis Towers Watson Public by 12.7% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 337 shares of the company’s stock worth $106,000 after purchasing an additional 38 shares during the last quarter. Glenmede Trust Co. NA increased its position in Willis Towers Watson Public by 3.1% during the third quarter. Glenmede Trust Co. NA now owns 1,419 shares of the company’s stock worth $418,000 after purchasing an additional 42 shares during the last quarter. Farther Finance Advisors LLC increased its position in shares of Willis Towers Watson Public by 22.2% in the third quarter. Farther Finance Advisors LLC now owns 237 shares of the company’s stock worth $70,000 after acquiring an additional 43 shares in the last quarter. Finally, UMB Bank n.a. increased its position in shares of Willis Towers Watson Public by 10.4% in the fourth quarter. UMB Bank n.a. now owns 520 shares of the company’s stock worth $163,000 after acquiring an additional 49 shares in the last quarter. Institutional investors and hedge funds own 93.09% of the company’s stock.
Willis Towers Watson Public Price Performance
Shares of WTW stock opened at $332.82 on Wednesday. The company has a market capitalization of $33.52 billion, a PE ratio of -332.82, a price-to-earnings-growth ratio of 2.95 and a beta of 0.74. The firm has a fifty day simple moving average of $319.34 and a 200-day simple moving average of $306.12. The company has a current ratio of 1.98, a quick ratio of 1.72 and a debt-to-equity ratio of 0.66. Willis Towers Watson Public Limited has a twelve month low of $245.04 and a twelve month high of $334.99.
Willis Towers Watson Public Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Monday, March 31st will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 1.11%. This is an increase from Willis Towers Watson Public’s previous quarterly dividend of $0.88. The ex-dividend date is Monday, March 31st. Willis Towers Watson Public’s dividend payout ratio is -352.00%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the stock. Barclays increased their price objective on shares of Willis Towers Watson Public from $278.00 to $302.00 and gave the stock an “underweight” rating in a research report on Thursday, November 21st. Wells Fargo & Company dropped their price objective on shares of Willis Towers Watson Public from $380.00 to $345.00 and set an “overweight” rating for the company in a research report on Tuesday, January 14th. Keefe, Bruyette & Woods increased their price objective on shares of Willis Towers Watson Public from $378.00 to $387.00 and gave the stock an “outperform” rating in a research report on Friday, January 10th. Raymond James raised shares of Willis Towers Watson Public from an “outperform” rating to a “strong-buy” rating and increased their price objective for the stock from $365.00 to $400.00 in a research report on Thursday, December 5th. Finally, Jefferies Financial Group raised shares of Willis Towers Watson Public from a “hold” rating to a “buy” rating and increased their price objective for the stock from $352.00 to $382.00 in a research report on Friday, December 20th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $342.08.
Willis Towers Watson Public Profile
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking. The company offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit program, including medical, dental, disability, life, voluntary benefits and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services.
Featured Stories
- Five stocks we like better than Willis Towers Watson Public
- What is a Stock Market Index and How Do You Use Them?
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Airline Stocks – Top Airline Stocks to Buy Now
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding WTW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Willis Towers Watson Public Limited (NASDAQ:WTW – Free Report).
Receive News & Ratings for Willis Towers Watson Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Towers Watson Public and related companies with MarketBeat.com's FREE daily email newsletter.